1-8 of 8
Pablo Mozas
Close
Sort by
Journal Articles

Varnimcabtagene Autoleucel (ARI-0001) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)

Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Gonzalo Del Campo Balguerías, Marta Español-Rego, Sergio Navarro, Irene Lopez-Oreja, Ferran Nadeu, Amparo Cobo, Helena Brillembourg, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Juan Gonzalo Correa, Andrea Rivero, Pablo Mozas, Eva Gine, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Mercedes Montoro-Lorite, Pilar Ayora, Carlos Fernández de Larrea, Mariona Pascal, Xavier Setoain, Jordi Esteve Reyner, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Journal: Blood
Blood (2023) 142 (Supplement 1): 3483.
https://doi.org/10.1182/blood-2023-182896
Published: 2023
Journal Articles

Impact of Salvage and Bridging Therapy in Adult Patients with Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Referred for Anti-CD19 CAR T-Cell Therapy: An Intention to Treat Analysis

Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Gonzalo Del Campo Balguerías, Marta Español-Rego, Sergio Navarro, Helena Brillembourg, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Juan Gonzalo Correa, Andrea Rivero, Pablo Mozas, Aina Oliver-Caldes, Eva Gine, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Mercedes Montoro-Lorite, Pilar Ayora, Carlos Fernández de Larrea, Mariona Pascal, Jordi Esteve Reyner, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Journal: Blood
Blood (2023) 142 (Supplement 1): 4875.
https://doi.org/10.1182/blood-2023-187226
Published: 2023
Journal Articles

Immunocompetent 3D Follicular Lymphoma Model: A Preclinical Tool to Design Tailored Immunotherapies

Cèlia Dobaño-López, Juan G Valero, Ferran Araujo-Ayala, Ferran Nadeu, Fabien Gava, Carla Faria, Marine Norlund, Renaud Morin, Pascale Bernes-Lasserre, Neus Serrat, Heribert Playa-Albinyana, Andrea Rivero, Pablo Mozas, Elías Campo, Jean-Michel Lagarde, Armando López-Guillermo, Dolors Colomer, Christine Bezombes, Patricia Pérez-Galán
Journal: Blood
Blood (2022) 140 (Supplement 1): 9279–9280.
https://doi.org/10.1182/blood-2022-166131
Published: 2022
Journal Articles

Mutational Profile and Copy Number Alterations of Follicular Lymphoma Patients with Different Clinical Behavior

Pablo Mozas, MD, Cristina López, PhD, Marta Grau, Sara Valle, Giancarlo Castellano, PhD, Alba Navarro, PhD, Ferran Nadeu, Blanca González-Farré, MD, Alfredo Rivas-Delgado, MD, Andrea Rivero, MD, Juan Gonzalo Correa, MD, Carlos Castillo, MD, Balagué Olga, MD PhD, Eva Giné, MD PhD, Julio Delgado, MD PhD, Neus Villamor, MD PhD, Magda Pinyol, PhD, Patricia Pérez-Galán, PhD, Laura Magnano, MD PhD, Elías Campo, MD PhD, Anna Enjuanes, PhD, Sílvia Beà, PhD, López-Guillermo Armando, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-140430
Published: 2020
Journal Articles

Mutational Landscape, Copy Number Alterations and Tumor Burden Assessed By Cell-Free DNA in Diffuse Large B-Cell Lymphoma

Alfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, Sebastián Casanueva, Laura Magnano, Natalia Castrejón de Anta, Jordina Rovira, Ivan Dlouhy, Pablo Mozas, Silvia Martín, Miguel Osuna, Tycho Baumann, Julio Delgado, Balagué Olga, Sílvia Beà, Neus Villamor, Xavier Setoain, Elías Campo, Eva Gine, MD, Armando Lopez-Guillermo
Journal: Blood
Blood (2019) 134 (Supplement_1): 4110.
https://doi.org/10.1182/blood-2019-128813
Published: 2019
Journal Articles

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Juan-Manuel Sancho, MD PhD, Olga García, Pablo Mozas, Santiago Mercadal, MD, Eva Donato, MD, Ana Muntañola Prat, MD, Javier Lopez Jimenez, MD, Pascual Fernandez Abellan, PhD, Jose-Angel Hernandez, MD, Maria J. Rodriguez-Salazar, MD, Samuel Romero, MD, Ana Marin Niebla, PhD, Angel Ramirez Payer, Raul Cordoba, MD PhD, Jose Luis Bello, MD, Beatriz Cuevas, MD, Itziar Oiartzabal, MD, Alejandro Martín, MD PhD, Jose Javier Sanchez Blanco, Nicholas Kelleher, MD, Ana Lafuente, MD, Marc Sorigué, MD, López Guillermo Armando, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5249.
https://doi.org/10.1182/blood-2019-125921
Published: 2019
Journal Articles

The U1 Spliceosomal RNA: A Novel Non-Coding Hotspot Driver Mutation Independently Associated with Clinical Outcome in Chronic Lymphocytic Leukemia

Ferran Nadeu, Shimin Shuai, Ander Diaz-Navarro, Irene López, Silvia Martín, Hiromichi Suzuki, Romina Royo, Guillem Clot, Julio Delgado, Tycho Baumann, Junyan Lu, PhD, Alba Navarro, Marta Kulis, Sachin A Kumar, Ana Gutierrez-Fernandez, Miguel Alcoceba, Marcos González, Enrique Colado, Angel Ramirez Payer, Cristina Capdevila, Miguel Osuna, Marta Aymerich, Rosó Mares, Monica Lopez-Guerra, Laura Magnano, Pablo Mozas, Alfredo Rivas-Delgado, Maria Jose Terol, Anna Enjuanes, Wolfgang Huber, PhD, Armando Lopez-Guillermo, Sílvia Beà, José I. Martin-Subero, Thorsten Zenz, MD, Michael D Taylor, Dolors Colomer, PhD, Xose S Puente, Lincoln D Stein, Elias Campo
Journal: Blood
Blood (2019) 134 (Supplement_1): 847.
https://doi.org/10.1182/blood-2019-130052
Published: 2019
Journal Articles

CLL: A Prognostic Model Comprising Only Two Biomarkers ( IGHV Mutational Status and FISH-Cytogenetics) Separates Patients with Different Prognosis and Simplifies the CLL-IPI.

Julio Delgado, MD, Michael Doubek, Tycho Baumann, Jana Kotaskova, MD PhD, Pablo Mozas, MD, Alfredo Rivas-Delgado, MD, Sarka Pospisilova, MD PhD, Emili Montserrat, MD
Journal: Blood
Blood (2016) 128 (22): 3205.
https://doi.org/10.1182/blood.V128.22.3205.3205
Published: 2016